You are here: Industry Insights > Sanofi

News List

Healthcare industry reported 70 deals worth $6.2 billion in January 2021: GlobalData expresspharma
February 08, 2021
In January 2021, the healthcare industry reported 70 deals worth $6.2 billion as compared to last 12-month average (January 2020 to December 2020) of 87 deals worth $17.1 billion.
500+ Sites Join Inato’s Industry Marketplace contractpharma
January 27, 2021
Inato, a global industry marketplace that matches research sites to the right clinical trial protocols, has announced that over 500 sites across more than 30 countries are participating in its Marketplace.
Sanofi to produce 100 million Pfizer/BioNTech vaccine doses: CEO expresspharma
January 27, 2021
Sanofi will produce more than 100 million doses of the COVID-19 vaccine developed by its competitors Pfizer and BioNTech by the end of the year, said Paul Hudson, CEO of Sanofi in an interview with Le Figaro newspaper.
BioPharma Companies Announce Formation of Accumulus Synergy americanpharmaceuticalreview
January 25, 2021
Ten biopharmaceutical companies announced the formation of a new non-profit corporation, Accumulus Synergy, Inc., which is intended to support interactions between industry and health authorities worldwide to enable real-time collaboration and data ...
Sanofi’s RSV treatment nirsevimab awarded PIM pharmatimes
January 22, 2021
Sanofi’s nirsevimab has been awarded a Promising Innovative Medicine (PIM) designation by the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK for the prevention of respiratory syncytial virus (RSV) associated lower respiratory ...
Sanofi Unveils EUROAPI as Name of New European API Company contractpharma
January 18, 2021
Sanofi has choosen EUROAPI as the name for the future European company dedicated to the development, production and marketing of active pharmaceutical ingredients (APIs).
Sanofi, Israel’s Biond Biologics to team up for new cancer drug expresspharma
January 15, 2021
Biond said that it will receive a $125 million upfront payment in cash under the deal.
Sanofi to acquire Kymab for up to $1.45bn pharmatimes
January 12, 2021
Sanofi will acquire Cambridge, UK-based biopharmaceutical company Kymab in a potential $1.45bn deal, which will see the French pharma add Kymab’s monoclonal antibody (mAB) KY1005 to its pipeline.
Sanofi and GSK postpone Covid-19 vaccine trial to optimise candidate pharmaceutical-technology
December 14, 2020
Sanofi and GlaxoSmithKline (GSK) have decided to delay their Covid-19 vaccine programme because their adjuvanted recombinant protein vaccine failed to produce a sufficient immune response in older adults enrolled in a US Phase I/II trial.
Sanofi’s meningococcal vaccine wins EU approval pharmatimes
November 25, 2020
French pharma company Sanofi has won approval from the European Commission (EC) for its meningococcal (MenACWY) vaccine MenQuadfi.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page